ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Immunogenicity of Personalized Genomic Vaccine to Treat Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02721043
Recruitment Status : Recruiting
First Posted : March 28, 2016
Last Update Posted : February 15, 2018
Sponsor:
Information provided by (Responsible Party):
Nina Bhardwaj, Icahn School of Medicine at Mount Sinai

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 2020
  Estimated Study Completion Date : July 2020